US Stock MarketDetailed Quotes

ITOS ITeos Therapeutics

Watchlist
  • 10.570
  • -0.420-3.82%
Close Apr 24 16:00 ET
  • 10.570
  • 0.0000.00%
Post 16:02 ET
378.86MMarket Cap-3355P/E (TTM)

ITeos Therapeutics Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
-95.29%12.6M
0
0
0
-91.74%12.6M
-22.38%267.63M
-77.59%53.91M
-81.31%19.49M
41.72M
152.52M
Operating revenue
-95.29%12.6M
--0
--0
--0
-91.74%12.6M
-22.38%267.63M
-77.59%53.91M
-81.31%19.49M
--41.72M
--152.52M
Cost of revenue
Gross profit
Operating expense
14.08%157.48M
5.98%37.24M
24.23%42.23M
9.21%41.44M
17.70%36.45M
53.91%138.04M
35.02%35.14M
45.44%33.99M
43.07%37.94M
124.81%30.97M
Selling and administrative expenses
14.67%50.4M
11.42%12.37M
17.49%12.64M
17.12%13.44M
12.36%11.93M
8.50%43.95M
15.66%11.1M
22.82%10.76M
-24.04%11.47M
50.65%10.62M
-General and administrative expense
14.67%50.4M
11.42%12.37M
17.49%12.64M
17.12%13.44M
12.36%11.93M
8.50%43.95M
15.66%11.1M
22.82%10.76M
-24.04%11.47M
50.65%10.62M
Research and development costs
16.37%113.3M
9.27%27.78M
28.02%30.64M
8.46%29.19M
21.34%25.6M
63.99%97.36M
46.22%25.42M
48.63%23.93M
89.00%26.91M
81.19%21.1M
Other operating expenses
-90.44%-6.21M
-110.21%-2.9M
-50.14%-1.05M
-169.93%-1.19M
-44.70%-1.08M
67.95%-3.26M
-44.31%-1.38M
53.12%-698K
84.43%-439K
84.84%-745K
Operating profit
-211.81%-144.89M
-298.48%-37.24M
-191.11%-42.23M
-1,197.93%-41.44M
-119.62%-23.85M
-49.20%129.59M
-91.25%18.76M
-117.93%-14.51M
114.23%3.77M
982.50%121.56M
Net non-operating interest income expense
179.68%31.77M
12.54%7.84M
147.89%8.04M
656.54%8.04M
8,433.70%7.85M
14,465.38%11.36M
6.97M
3.24M
1.06M
92K
Non-operating interest income
179.68%31.77M
12.54%7.84M
147.89%8.04M
656.54%8.04M
8,433.70%7.85M
14,465.38%11.36M
--6.97M
--3.24M
--1.06M
--92K
Other net income (expense)
-47.57%4.08M
140.62%1.21M
-91.69%771K
-90.96%326K
177.97%1.65M
497.24%7.79M
-131.47%-2.99M
209.36%9.28M
5,910.00%3.61M
-981.25%-2.12M
Other non- operating income (expenses)
-47.57%4.08M
140.62%1.21M
-91.69%771K
-90.96%326K
177.97%1.65M
497.24%7.79M
-131.47%-2.99M
209.36%9.28M
5,910.00%3.61M
-981.25%-2.12M
Income before tax
-173.30%-109.03M
-223.93%-28.19M
-1,582.88%-33.42M
-491.66%-33.07M
-112.01%-14.35M
-42.01%148.74M
-89.85%22.75M
-102.74%-1.99M
131.91%8.44M
983.21%119.53M
Income tax
-93.07%3.61M
3.05%2.36M
60.33%-1.18M
-56.27%1.23M
-97.60%1.2M
24.18%52.08M
-94.15%2.29M
-207.43%-2.98M
2.82M
49.95M
Net income
-216.54%-112.64M
-249.37%-30.55M
-3,353.38%-32.24M
-709.67%-34.3M
-122.35%-15.55M
-54.95%96.65M
-88.94%20.45M
-98.58%991K
121.26%5.63M
614.13%69.58M
Net income continuous Operations
-216.54%-112.64M
-249.37%-30.55M
-3,353.38%-32.24M
-709.67%-34.3M
-122.35%-15.55M
-54.95%96.65M
-88.94%20.45M
-98.58%991K
121.26%5.63M
614.13%69.58M
Minority interest income
Net income attributable to the parent company
-216.54%-112.64M
-249.37%-30.55M
-3,353.38%-32.24M
-709.67%-34.3M
-122.35%-15.55M
-54.95%96.65M
-88.94%20.45M
-98.58%991K
121.26%5.63M
614.13%69.58M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-216.54%-112.64M
-249.37%-30.55M
-3,353.38%-32.24M
-709.67%-34.3M
-122.35%-15.55M
-54.95%96.65M
-88.94%20.45M
-98.58%991K
121.26%5.63M
614.13%69.58M
Basic earnings per share
-215.81%-3.15
-246.55%-0.85
-3,100.00%-0.9
-700.00%-0.96
-122.45%-0.44
-55.41%2.72
-88.97%0.58
-98.48%0.03
121.33%0.16
602.56%1.96
Diluted earnings per share
-223.05%-3.15
-254.55%-0.85
-3,100.00%-0.9
-740.00%-0.96
-124.18%-0.44
-54.93%2.56
-88.75%0.55
-98.39%0.03
120.00%0.15
566.67%1.82
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue -95.29%12.6M000-91.74%12.6M-22.38%267.63M-77.59%53.91M-81.31%19.49M41.72M152.52M
Operating revenue -95.29%12.6M--0--0--0-91.74%12.6M-22.38%267.63M-77.59%53.91M-81.31%19.49M--41.72M--152.52M
Cost of revenue
Gross profit
Operating expense 14.08%157.48M5.98%37.24M24.23%42.23M9.21%41.44M17.70%36.45M53.91%138.04M35.02%35.14M45.44%33.99M43.07%37.94M124.81%30.97M
Selling and administrative expenses 14.67%50.4M11.42%12.37M17.49%12.64M17.12%13.44M12.36%11.93M8.50%43.95M15.66%11.1M22.82%10.76M-24.04%11.47M50.65%10.62M
-General and administrative expense 14.67%50.4M11.42%12.37M17.49%12.64M17.12%13.44M12.36%11.93M8.50%43.95M15.66%11.1M22.82%10.76M-24.04%11.47M50.65%10.62M
Research and development costs 16.37%113.3M9.27%27.78M28.02%30.64M8.46%29.19M21.34%25.6M63.99%97.36M46.22%25.42M48.63%23.93M89.00%26.91M81.19%21.1M
Other operating expenses -90.44%-6.21M-110.21%-2.9M-50.14%-1.05M-169.93%-1.19M-44.70%-1.08M67.95%-3.26M-44.31%-1.38M53.12%-698K84.43%-439K84.84%-745K
Operating profit -211.81%-144.89M-298.48%-37.24M-191.11%-42.23M-1,197.93%-41.44M-119.62%-23.85M-49.20%129.59M-91.25%18.76M-117.93%-14.51M114.23%3.77M982.50%121.56M
Net non-operating interest income expense 179.68%31.77M12.54%7.84M147.89%8.04M656.54%8.04M8,433.70%7.85M14,465.38%11.36M6.97M3.24M1.06M92K
Non-operating interest income 179.68%31.77M12.54%7.84M147.89%8.04M656.54%8.04M8,433.70%7.85M14,465.38%11.36M--6.97M--3.24M--1.06M--92K
Other net income (expense) -47.57%4.08M140.62%1.21M-91.69%771K-90.96%326K177.97%1.65M497.24%7.79M-131.47%-2.99M209.36%9.28M5,910.00%3.61M-981.25%-2.12M
Other non- operating income (expenses) -47.57%4.08M140.62%1.21M-91.69%771K-90.96%326K177.97%1.65M497.24%7.79M-131.47%-2.99M209.36%9.28M5,910.00%3.61M-981.25%-2.12M
Income before tax -173.30%-109.03M-223.93%-28.19M-1,582.88%-33.42M-491.66%-33.07M-112.01%-14.35M-42.01%148.74M-89.85%22.75M-102.74%-1.99M131.91%8.44M983.21%119.53M
Income tax -93.07%3.61M3.05%2.36M60.33%-1.18M-56.27%1.23M-97.60%1.2M24.18%52.08M-94.15%2.29M-207.43%-2.98M2.82M49.95M
Net income -216.54%-112.64M-249.37%-30.55M-3,353.38%-32.24M-709.67%-34.3M-122.35%-15.55M-54.95%96.65M-88.94%20.45M-98.58%991K121.26%5.63M614.13%69.58M
Net income continuous Operations -216.54%-112.64M-249.37%-30.55M-3,353.38%-32.24M-709.67%-34.3M-122.35%-15.55M-54.95%96.65M-88.94%20.45M-98.58%991K121.26%5.63M614.13%69.58M
Minority interest income
Net income attributable to the parent company -216.54%-112.64M-249.37%-30.55M-3,353.38%-32.24M-709.67%-34.3M-122.35%-15.55M-54.95%96.65M-88.94%20.45M-98.58%991K121.26%5.63M614.13%69.58M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -216.54%-112.64M-249.37%-30.55M-3,353.38%-32.24M-709.67%-34.3M-122.35%-15.55M-54.95%96.65M-88.94%20.45M-98.58%991K121.26%5.63M614.13%69.58M
Basic earnings per share -215.81%-3.15-246.55%-0.85-3,100.00%-0.9-700.00%-0.96-122.45%-0.44-55.41%2.72-88.97%0.58-98.48%0.03121.33%0.16602.56%1.96
Diluted earnings per share -223.05%-3.15-254.55%-0.85-3,100.00%-0.9-740.00%-0.96-124.18%-0.44-54.93%2.56-88.75%0.55-98.39%0.03120.00%0.15566.67%1.82
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg